170 related articles for article (PubMed ID: 31570787)
1. Bile acid-induced "Minority MOMP" promotes esophageal carcinogenesis while maintaining apoptotic resistance via Mcl-1.
Xu Y; Surman DR; Diggs L; Xi S; Gao S; Gurusamy D; McLoughlin K; Drake J; Feingold P; Brown K; Wangsa D; Wangsa D; Zhang X; Ried T; Davis JL; Hernandez J; Hoang CD; Souza RF; Schrump DS; Taylor Ripley R
Oncogene; 2020 Jan; 39(4):877-890. PubMed ID: 31570787
[TBL] [Abstract][Full Text] [Related]
2. In Barrett's esophagus patients and Barrett's cell lines, ursodeoxycholic acid increases antioxidant expression and prevents DNA damage by bile acids.
Peng S; Huo X; Rezaei D; Zhang Q; Zhang X; Yu C; Asanuma K; Cheng E; Pham TH; Wang DH; Chen M; Souza RF; Spechler SJ
Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(2):G129-39. PubMed ID: 24852569
[TBL] [Abstract][Full Text] [Related]
3. Cancer-related inflammation and Barrett's carcinogenesis: interleukin-6 and STAT3 mediate apoptotic resistance in transformed Barrett's cells.
Zhang HY; Zhang Q; Zhang X; Yu C; Huo X; Cheng E; Wang DH; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G454-60. PubMed ID: 21148399
[TBL] [Abstract][Full Text] [Related]
4. Toll-like Receptor 2 Signalling and the Lysosomal Machinery in Barrett's Esophagus.
Verbeek RE; Siersema PD; Vleggaar FP; Ten Kate FJ; Posthuma G; Souza RF; de Haan J; van Baal JW
J Gastrointestin Liver Dis; 2016 Sep; 25(3):273-82. PubMed ID: 27689189
[TBL] [Abstract][Full Text] [Related]
5. Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cells.
Huo X; Juergens S; Zhang X; Rezaei D; Yu C; Strauch ED; Wang JY; Cheng E; Meyer F; Wang DH; Zhang Q; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G278-86. PubMed ID: 21636532
[TBL] [Abstract][Full Text] [Related]
6. Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett's oesophageal adenocarcinoma.
Morita S; Matsumoto Y; Okuyama S; Ono K; Kitamura Y; Tomori A; Oyama T; Amano Y; Kinoshita Y; Chiba T; Marusawa H
Carcinogenesis; 2011 Nov; 32(11):1706-12. PubMed ID: 21890457
[TBL] [Abstract][Full Text] [Related]
7. Activation of the interleukin-6/STAT3 antiapoptotic pathway in esophageal cells by bile acids and low pH: relevance to barrett's esophagus.
Dvorak K; Chavarria M; Payne CM; Ramsey L; Crowley-Weber C; Dvorakova B; Dvorak B; Bernstein H; Holubec H; Sampliner RE; Bernstein C; Prasad A; Green SB; Garewal H
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5305-13. PubMed ID: 17875759
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of oxidant production in esophageal squamous cell and Barrett's cell lines.
Feagins LA; Zhang HY; Zhang X; Hormi-Carver K; Thomas T; Terada LS; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G411-7. PubMed ID: 18063706
[TBL] [Abstract][Full Text] [Related]
9. Host factors influence Barrett's carcinogenesis: findings from a mouse gastroduodenal reflux model.
Kanai S; Mukaisho KI; Yoshida S; Taniura N; Sugihara H
Esophagus; 2019 Jul; 16(3):264-271. PubMed ID: 30790117
[TBL] [Abstract][Full Text] [Related]
10. Acidic Bile Salts Induce Epithelial to Mesenchymal Transition via VEGF Signaling in Non-Neoplastic Barrett's Cells.
Zhang Q; Agoston AT; Pham TH; Zhang W; Zhang X; Huo X; Peng S; Bajpai M; Das K; Odze RD; Spechler SJ; Souza RF
Gastroenterology; 2019 Jan; 156(1):130-144.e10. PubMed ID: 30268789
[TBL] [Abstract][Full Text] [Related]
11. Bile acids increase levels of microRNAs 221 and 222, leading to degradation of CDX2 during esophageal carcinogenesis.
Matsuzaki J; Suzuki H; Tsugawa H; Watanabe M; Hossain S; Arai E; Saito Y; Sekine S; Akaike T; Kanai Y; Mukaisho K; Auwerx J; Hibi T
Gastroenterology; 2013 Dec; 145(6):1300-11. PubMed ID: 23933602
[TBL] [Abstract][Full Text] [Related]
12. The bile acid deoxycholic acid has a non-linear dose response for DNA damage and possibly NF-kappaB activation in oesophageal cells, with a mechanism of action involving ROS.
Jenkins GJ; Cronin J; Alhamdani A; Rawat N; D'Souza F; Thomas T; Eltahir Z; Griffiths AP; Baxter JN
Mutagenesis; 2008 Sep; 23(5):399-405. PubMed ID: 18515815
[TBL] [Abstract][Full Text] [Related]
13. From Reflux Esophagitis to Esophageal Adenocarcinoma.
Souza RF
Dig Dis; 2016; 34(5):483-90. PubMed ID: 27331918
[TBL] [Abstract][Full Text] [Related]
14. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
[TBL] [Abstract][Full Text] [Related]
15. Bile acids induce overexpression of homeobox gene CDX-2 and vascular endothelial growth factor (VEGF) in human Barrett's esophageal mucosa and adenocarcinoma cell line.
Burnat G; Rau T; Elshimi E; Hahn EG; Konturek PC
Scand J Gastroenterol; 2007 Dec; 42(12):1460-5. PubMed ID: 17852856
[TBL] [Abstract][Full Text] [Related]
16. Exposure of Barrett's and esophageal adenocarcinoma cells to bile acids activates EGFR-STAT3 signaling axis via induction of APE1.
Bhat AA; Lu H; Soutto M; Capobianco A; Rai P; Zaika A; El-Rifai W
Oncogene; 2018 Nov; 37(46):6011-6024. PubMed ID: 29991802
[TBL] [Abstract][Full Text] [Related]
17. Bile salt exposure increases proliferation through p38 and ERK MAPK pathways in a non-neoplastic Barrett's cell line.
Jaiswal K; Lopez-Guzman C; Souza RF; Spechler SJ; Sarosi GA
Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G335-42. PubMed ID: 16239404
[TBL] [Abstract][Full Text] [Related]
18. Bile salts differentially sensitize esophageal squamous cells to CD95 (Fas/Apo-1 receptor) mediated apoptosis.
Naran S; Abrams P; de Oliveira PQ; Hughes SJ
J Surg Res; 2011 Dec; 171(2):504-9. PubMed ID: 20934723
[TBL] [Abstract][Full Text] [Related]
19. MCL-1ES induces MCL-1L-dependent BAX- and BAK-independent mitochondrial apoptosis.
Kim JH; Bae J
PLoS One; 2013; 8(11):e79626. PubMed ID: 24260268
[TBL] [Abstract][Full Text] [Related]
20. Bile acids are multifunctional modulators of the Barrett's carcinogenesis.
Burnat G; Majka J; Konturek PC
J Physiol Pharmacol; 2010 Apr; 61(2):185-92. PubMed ID: 20436219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
